Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $12.9700 (-3.21%) ($12.7450 - $12.9700) on Thu. Dec. 1, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.49% (three month average) | RSI | 50 | Latest Price | $12.9700(-3.21%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 0.9% a day on average for past five trading days. | Weekly Trend | BCRX declines -1.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) URA(24%) XLK(22%) VUG(21%) BLOK(20%) VT(19%) | Factors Impacting BCRX price | BCRX will decline at least -1.745% in a week (0% probabilities). SMH(-24%) ARKG(-14%) VIXM(-11%) SHY(-6%) TLT(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.745% (StdDev 3.49%) | Hourly BBV | 0.6 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $12.7(2.13%) | 10 Day Moving Average | $12.58(3.1%) | 20 Day Moving Average | $12.61(2.85%) | To recent high | -8.8% | To recent low | 10.5% | Market Cap | $2.288b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |